Results of a Single-Institution Experience With Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer

被引：0
|
作者：
Bernard, M. [1 ]
Glaser, S. M. [1 ]
Gill, B. S. [1 ]
Beriwal, S. [1 ]
Heron, D. E. [2 ]
Luketich, J. [3 ]
Friedland, D. [4 ]
Socinski, M. [4 ]
Greenberger, J. S. [5 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Univ Pittsburgh, Inst Canc, Dept Thorac Surg 2, Pittsburgh, PA USA
[4] Univ Pittsburgh, Inst Canc, Dept Med Oncol, Pittsburgh, PA USA
[5] UPMC Shadyside Hosp, Pittsburgh, PA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1758
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3105
引用
收藏
页码：E449 / E449
页数：1
相关论文
共 50 条
  • [41] Use of Thoracic Chemoradiation in Very Elderly Non-small Cell Lung Cancer Patients Age 80 Years and Older: A Single-Institution Experience
    Daniels, T. B.
    Zhao, L.
    Sio, T. T. W.
    Paripati, H.
    Wampfler, J.
    Ross, H.
    Yang, P.
    Schild, S. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E450 - E450
  • [42] Impact of Dose-Escalated Chemoradiation on Pathological Complete Response in Patients with Locally Advanced Rectal Cancer
    Domingo-Boluda, Carolina
    Dualde, Diego
    Taberner-Bonastre, Teresa
    Soler, Miguel
    Lopez-Campos, Fernando
    CANCERS, 2024, 16 (18)
  • [43] Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
    Price, Katharine A. R.
    Azzoli, Christopher G.
    Gaspar, Laurie E.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 204 - 209
  • [44] A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC).
    Hoffman, PC
    Mauer, AM
    Haraf, DC
    Lester, EP
    Szeto, LL
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
  • [45] Accelerated hypofractionated chemoradiation followed by stereotactic ablative radiotherapy boost for locally advanced, unresectable non-small cell lung cancer
    Weber, Urs M.
    Watson, Alexander S.
    Kavanagh, Brian D.
    Bunn, Paul A.
    TRANSLATIONAL CANCER RESEARCH, 2025, 14 (02) : 676 - 678
  • [46] 5-YEAR SINGLE-INSTITUTION EXPERIENCE OF SINGLE-FRACTION SABR FOR NON-SMALL CELL LUNG CANCER
    Bouchard, Myriam
    Caron, Anthony
    Turgeon, Guy-Anne
    Provencher, Sawyna
    Lavoie-Gagnon, Heloise
    Amzallag, Daniel
    Soucy, Isabelle
    Lemaire-Paquette, Samuel
    Plourde, Marc-Emile
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S19 - S20
  • [47] 5-Year Single-Institution Experience of Single-Fraction SABR for Non-Small Cell Lung Cancer
    Bouchard, M.
    Caron, A.
    Turgeon, G. A.
    Provencher, S.
    Lavoie-Gagnon, H.
    Amzallag, D.
    Soucy, I.
    Lemaire-Paquette, S.
    Plourde, M. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E7 - E7
  • [48] Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer
    Weiss, Glen J.
    Zeng, Chan
    Kelly, Karen
    Tran, Zung Vu
    Bunn, Paul A., Jr.
    CLINICAL LUNG CANCER, 2007, 8 (05) : 335 - 338
  • [49] Radiation dose effect in locally advanced non-small cell lung cancer
    Kong, Feng-Ming
    Zhao, Jing
    Wang, Jingbo
    Faivre-Finn, Corrine
    JOURNAL OF THORACIC DISEASE, 2014, 6 (04) : 336 - 347
  • [50] The Importance of Radiotherapy Dose in the Management of Locally Advanced Non-small Cell Lung Cancer: The Manitoba Experience
    Mou, B.
    Liu, H. W.
    Hunter, W. M.
    Nugent, Z.
    Lyn, B. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S594 - S594
12345